431 related articles for article (PubMed ID: 28277610)
1. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.
Lawal RA; Zhou X; Batey K; Hoffman CM; Georger MA; Radtke F; Hilton MJ; Xing L; Frisch BJ; Calvi LM
J Bone Miner Res; 2017 Jun; 32(6):1320-1331. PubMed ID: 28277610
[TBL] [Abstract][Full Text] [Related]
2. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.
Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM
Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.
Weber JM; Forsythe SR; Christianson CA; Frisch BJ; Gigliotti BJ; Jordan CT; Milner LA; Guzman ML; Calvi LM
Bone; 2006 Sep; 39(3):485-93. PubMed ID: 16647886
[TBL] [Abstract][Full Text] [Related]
4. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
[TBL] [Abstract][Full Text] [Related]
6. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
7. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
[TBL] [Abstract][Full Text] [Related]
10. SLPI is a critical mediator that controls PTH-induced bone formation.
Morimoto A; Kikuta J; Nishikawa K; Sudo T; Uenaka M; Furuya M; Hasegawa T; Hashimoto K; Tsukazaki H; Seno S; Nakamura A; Okuzaki D; Sugihara F; Ninomiya A; Yoshimura T; Takao-Kawabata R; Matsuda H; Ishii M
Nat Commun; 2021 Apr; 12(1):2136. PubMed ID: 33837198
[TBL] [Abstract][Full Text] [Related]
11. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation.
Wagley Y; Chesi A; Acevedo PK; Lu S; Wells AD; Johnson ME; Grant SFA; Hankenson KD
Stem Cells; 2020 Oct; 38(10):1332-1347. PubMed ID: 32535942
[TBL] [Abstract][Full Text] [Related]
12. The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.
Shu L; Ji J; Zhu Q; Cao G; Karaplis A; Pollak MR; Brown E; Goltzman D; Miao D
J Bone Miner Res; 2011 May; 26(5):1057-71. PubMed ID: 21542007
[TBL] [Abstract][Full Text] [Related]
13. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
15. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
[TBL] [Abstract][Full Text] [Related]
16. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
[TBL] [Abstract][Full Text] [Related]
17. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
[TBL] [Abstract][Full Text] [Related]
18. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
19. The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone-Related Peptide.
Zhu M; Zhang J; Dong Z; Zhang Y; Wang R; Karaplis A; Goltzman D; Miao D
J Bone Miner Res; 2015 Nov; 30(11):1969-79. PubMed ID: 25917430
[TBL] [Abstract][Full Text] [Related]
20. [Bone histology after intermittent PTH treatment - animal models -].
Sasaki M; Hasegawa T; Hongo H; Yamamoto T; Amizuka N
Clin Calcium; 2013 Mar; 23(3):347-53. PubMed ID: 23445886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
